Gemfibrozil
- Product NDC
- 0615-3559
- 11-digit product format
- 006153559
- Labeler code
- 0615
- Product ID
- 0615-3559_26fa7a1a-4426-4f35-aeea-af695b8beb27
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gemfibrozil
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA074256
- Marketing category
- ANDA
- Marketing start
- 1993-11-24
- Marketing end
- 0000-00-00
- Substance
- GEMFIBROZIL
- Active strength
- 600 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-3559-30 | 2021-05-06 | C162847 | 48780-1 | 9d75b9d0-9280-f424-e053-dadaa90a57ce | 3aded695-fcaa-45b9-b780-8182caf79ff6 |
| 0615-3559-31 | 2021-05-06 | C162847 | 48780-1 | 9d75b9d0-9280-f424-e053-dadaa90a57ce | 3aded695-fcaa-45b9-b780-8182caf79ff6 |
| 0615-3559-39 | 2021-05-06 | C162847 | 48780-1 | 9d75b9d0-9280-f424-e053-dadaa90a57ce | 3aded695-fcaa-45b9-b780-8182caf79ff6 |
| 0615-3559-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-9280-f424-e053-dadaa90a57ce | 3aded695-fcaa-45b9-b780-8182caf79ff6 |
| 0615-3559-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-9280-f424-e053-dadaa90a57ce | 3aded695-fcaa-45b9-b780-8182caf79ff6 |
| 0615-3559-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-9280-f424-e053-dadaa90a57ce | 3aded695-fcaa-45b9-b780-8182caf79ff6 |